ProBiotix Health Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	2.13	1.67	1.12	1.1	0.82	0.37
Revenue Growth (YoY)	70.66%	49.19%	1.93%	33.98%	123.60%	-
Cost of Revenue	0.96	0.8	0.48	0.55	0.31	0.1
Gross Profit	1.17	0.87	0.64	0.55	0.51	0.27
Selling, General & Admin	1.64	1.58	0.72	0.45	0.46	0.39
Research & Development	-	-	-	-	-	0.18
Other Operating Expenses	-	-	-	-	-	0.13
Operating Expenses	1.69	1.63	0.76	0.45	0.46	0.7
Operating Income	-0.52	-0.76	-0.12	0.11	0.05	-0.43
Interest Expense	-	-	0.01	-0.06	-0.06	-0.05
Interest & Investment Income	-	-	0.06	-	-	-
Other Non Operating Income (Expenses)	-	-	-0.17	-	-	-
Pretax Income	-0.52	-0.76	-0.22	0.04	-0.01	-0.49
Income Tax Expense	-0.02	-0.02	0.01	0.01	-	0.04
Net Income	-0.5	-0.75	-0.23	0.04	-0.01	-0.52
Net Income to Common	-0.5	-0.75	-0.23	0.04	-0.01	-0.52
Shares Outstanding (Basic)	122	122	90	0	0	-
Shares Outstanding (Diluted)	122	122	90	0	0	-
Shares Change (YoY)	23.88%	34.59%	90298.56%	-	-	-
EPS (Basic)	-0.00	-0.01	-0.00	0.36	-0.13	-
EPS (Diluted)	-0.00	-0.01	-0.00	0.36	-0.13	-
Gross Margin	55.10%	52.12%	57.10%	50.44%	61.90%	72.74%
Operating Margin	-24.35%	-45.55%	-11.01%	9.62%	5.62%	-117.94%
Profit Margin	-23.32%	-44.65%	-20.66%	3.30%	-1.62%	-142.48%
EBITDA	-0.47	-0.71	-0.09	-	-	-
EBITDA Margin	-21.96%	-42.38%	-8.18%	-	-	-
D&A For EBITDA	0.05	0.05	0.03	-	-	-
EBIT	-0.52	-0.76	-0.12	0.11	0.05	-0.43
EBIT Margin	-24.35%	-45.55%	-11.01%	9.62%	5.62%	-117.94%
Effective Tax Rate	-	-	-	15.17%	-	-

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.